BindingDB Entry 50042936: Discovery of SAR184841, a potent and long-lasting inhibitor of 11ß-hydroxysteroid dehydrogenase type 1, active in a physiopathological animal model of T2D.

Name: BindingDB Entry 50042936: Discovery of SAR184841, a potent and long-lasting inhibitor of 11ß-hydroxysteroid dehydrogenase type 1, active in a physiopathological animal model of T2D.
Creator: BindingDB
Keywords: 11-beta-Hydroxysteroid Dehydrogenase 1 (11-beta-HSD1), 11-beta-hydroxysteroid dehydrogenase 1, and 11-beta-hydroxysteroid dehydrogenase 2, Sanofi R&D, Affinity

Research datakeyboard_double_arrow_right Dataset 01 Jan 2014 English Publisher:BindingDB

Authors: BindingDB;

doi: 10.7270/q2nv9kmn

BindingDB Entry 50042936: Discovery of SAR184841, a potent and long-lasting inhibitor of 11ß-hydroxysteroid dehydrogenase type 1, active in a physiopathological animal model of T2D.

- Summary
- Subjects
- Related research
  (24)
- Metrics

tips_and_updates
Recommended

Abstract

Small molecule binding data for protein 11-beta-Hydroxysteroid Dehydrogenase 1 (11-beta-HSD1), 11-beta-hydroxysteroid dehydrogenase 1, and 11-beta-hydroxysteroid dehydrogenase 2, Uniprot P16232, P28845, P50172, and P80365

Keywords

11-beta-Hydroxysteroid Dehydrogenase 1 (11-beta-HSD1), 11-beta-hydroxysteroid dehydrogenase 1, and 11-beta-hydroxysteroid dehydrogenase 2, Sanofi R&D, Affinity

24 Research products, page 1 of 3

BindingDB Entry 50043187: Mono-carbonyl curcumin analogues as 11ß-hydroxysteroid dehydrogenase 1 inhibitors.
2014IsAmongTopNSimilarDocuments
BindingDB Entry 50019128: Discovery and metabolic stabilization of potent and selective 2-amino-N-(adamant-2-yl) acetamide 11beta-hydroxysteroid dehydrogenase type 1 inhibitors.
2009IsAmongTopNSimilarDocuments
Higher 11-beta-hydroxysteroid dehydrogenase type I gene expression in white adipose tissue in male than female rats.
2012IsAmongTopNSimilarDocuments
BindingDB Entry 50018414: Discovery of potent and selective inhibitors of 11beta-HSD1 for the treatment of metabolic syndrome.
2009IsAmongTopNSimilarDocuments
BindingDB Entry 3391: Discovery and initial SAR of arylsulfonylpiperazine inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1).
2009IsAmongTopNSimilarDocuments
BindingDB Entry 50026475: Piperazine sulfonamides as potent, selective, and orally available 11beta-hydroxysteroid dehydrogenase type 1 inhibitors with efficacy in the rat cortisone-induced hyperinsulinemia model.
2010IsAmongTopNSimilarDocuments
BindingDB Entry 50038789: Optimization of novel di-substituted cyclohexylbenzamide derivatives as potent 11 beta-HSD1 inhibitors.
2012IsAmongTopNSimilarDocuments
BindingDB Entry 50043940: Optimization of brain penetrant 11ß-hydroxysteroid dehydrogenase type I inhibitors and in vivo testing in diet-induced obese mice.
2014IsAmongTopNSimilarDocuments
BindingDB Entry 50043078: Evaluation of selective inhibitors of 11ß-HSD1 for the treatment of hypertension.
2014IsAmongTopNSimilarDocuments
BindingDB Entry 50027771: Further studies with the 2-amino-1,3-thiazol-4(5H)-one class of 11beta-hydroxysteroid dehydrogenase type 1 inhibitors: reducing pregnane X receptor activity and exploring activity in a monkey pharmacodynamic model.
2010IsAmongTopNSimilarDocuments

chevron_left
1
2
3
chevron_right

Impact byBIP!

	citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	0
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average